Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Nuvectis Pharma Inc (NVCT)

Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference GlobeNewswire - Fri May 16, 3:35PM CDT

NVCT : 7.98 (+0.25%)
Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights GlobeNewswire - Tue May 6, 7:00AM CDT

NVCT : 7.98 (+0.25%)
Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting GlobeNewswire - Tue Apr 29, 3:25PM CDT

NVCT : 7.98 (+0.25%)
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting GlobeNewswire - Wed Mar 26, 7:00AM CDT

NVCT : 7.98 (+0.25%)
Nuvectis Pharma to Participate in the 37th Annual Roth Conference GlobeNewswire - Fri Mar 14, 7:00AM CDT

NVCT : 7.98 (+0.25%)
Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR Inhibitors Improves the Efficacy of the EGFR Inhibitors in Preclinical Models of EGFR Mutated NSCLC GlobeNewswire - Tue Mar 4, 7:00AM CST

NVCT : 7.98 (+0.25%)
Nuvectis Pharma, Inc. Reports 2024 Financial Results and Business Highlights GlobeNewswire - Tue Feb 25, 7:00AM CST

NVCT : 7.98 (+0.25%)
Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option GlobeNewswire - Fri Feb 7, 7:30AM CST

NVCT : 7.98 (+0.25%)
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock GlobeNewswire - Wed Feb 5, 8:01AM CST

NVCT : 7.98 (+0.25%)
Nuvectis Pharma Announces Proposed Public Offering of Common Stock GlobeNewswire - Tue Feb 4, 3:05PM CST

NVCT : 7.98 (+0.25%)

Barchart Exclusives

Target Just Raised Its Dividend. Should You Buy TGT Stock Here? Barchart - Wed Jun 25, 12:15AM CDT
Target raised its payout again. Is that reason enough for dividend-focused investors to grab shares now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot